New Equilibrium Bio

Background New Equilibrium Bio
New Equilibrium Bio Virginia Burger, Co-Founder & CEO of New Equilibrium Bio

New Equilibrium Biosciences leverages their computational–experimental platform to discover lead drug candidates that regulate intrinsically disordered proteins implicated in cancers and neurodegenerative disorders.

Co-investors

RA Capital

University Spinout

MIT